CINEVERSE CORP (CNVS) Fundamental Analysis & Valuation

NASDAQ:CNVS • US1724063086

Current stock price

2.5 USD
+0.06 (+2.46%)
Last:

This CNVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CNVS Profitability Analysis

1.1 Basic Checks

  • CNVS had negative earnings in the past year.
  • In the past year CNVS has reported a negative cash flow from operations.
  • In multiple years CNVS reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CNVS reported negative operating cash flow in multiple years.
CNVS Yearly Net Income VS EBIT VS OCF VS FCFCNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • The Return On Assets of CNVS (-13.97%) is worse than 70.89% of its industry peers.
  • With a Return On Equity value of -24.84%, CNVS perfoms like the industry average, outperforming 41.77% of the companies in the same industry.
Industry RankSector Rank
ROA -13.97%
ROE -24.84%
ROIC N/A
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
CNVS Yearly ROA, ROE, ROICCNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • CNVS's Profit Margin has improved in the last couple of years.
  • CNVS's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 60.05%, CNVS is doing good in the industry, outperforming 67.09% of the companies in the same industry.
  • CNVS's Gross Margin has declined in the last couple of years.
  • CNVS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.05%
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
CNVS Yearly Profit, Operating, Gross MarginsCNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CNVS Health Analysis

2.1 Basic Checks

  • CNVS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CNVS has more shares outstanding
  • Compared to 5 years ago, CNVS has more shares outstanding
  • There is no outstanding debt for CNVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CNVS Yearly Shares OutstandingCNVS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CNVS Yearly Total Debt VS Total AssetsCNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -8.98, we must say that CNVS is in the distress zone and has some risk of bankruptcy.
  • CNVS has a Altman-Z score of -8.98. This is amonst the worse of the industry: CNVS underperforms 83.54% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that CNVS is not too dependend on debt financing.
  • CNVS has a Debt to Equity ratio (0.21) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -8.98
ROIC/WACCN/A
WACC10.17%
CNVS Yearly LT Debt VS Equity VS FCFCNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.95 indicates that CNVS may have some problems paying its short term obligations.
  • CNVS has a Current ratio (0.95) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.95 indicates that CNVS may have some problems paying its short term obligations.
  • CNVS has a Quick ratio of 0.95. This is comparable to the rest of the industry: CNVS outperforms 40.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
CNVS Yearly Current Assets VS Current LiabilitesCNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CNVS Growth Analysis

3.1 Past

  • The earnings per share for CNVS have decreased strongly by -4900.00% in the last year.
  • The earnings per share for CNVS have been decreasing by -23.37% on average. This is quite bad
  • Looking at the last year, CNVS shows a very negative growth in Revenue. The Revenue has decreased by -23.64% in the last year.
  • Measured over the past years, CNVS shows a quite strong growth in Revenue. The Revenue has been growing by 14.75% on average per year.
EPS 1Y (TTM)-4900%
EPS 3Y-23.37%
EPS 5YN/A
EPS Q2Q%-105.88%
Revenue 1Y (TTM)-23.64%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%-60.02%

3.2 Future

  • CNVS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.87% yearly.
  • CNVS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.57% yearly.
EPS Next Y-734.67%
EPS Next 2Y-45.37%
EPS Next 3Y66.87%
EPS Next 5YN/A
Revenue Next Year-19.85%
Revenue Next 2Y21.58%
Revenue Next 3Y18.57%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNVS Yearly Revenue VS EstimatesCNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
CNVS Yearly EPS VS EstimatesCNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 2021 2022 2023 2024 2025 2026 2027 2028 0 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. CNVS Valuation Analysis

4.1 Price/Earnings Ratio

  • CNVS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CNVS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVS Price Earnings VS Forward Price EarningsCNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNVS Per share dataCNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CNVS's earnings are expected to grow with 66.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.37%
EPS Next 3Y66.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CNVS Dividend Analysis

5.1 Amount

  • CNVS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CNVS Fundamentals: All Metrics, Ratios and Statistics

CINEVERSE CORP

NASDAQ:CNVS (4/8/2026, 10:40:07 AM)

2.5

+0.06 (+2.46%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-17
Earnings (Next)06-25
Inst Owners18.36%
Inst Owner Change-1.29%
Ins Owners10.93%
Ins Owner Change10.02%
Market Cap53.23M
Revenue(TTM)55.34M
Net Income(TTM)-9.58M
Analysts82.5
Price Target11.22 (348.8%)
Short Float %2.79%
Short Ratio1.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.07%
Min EPS beat(2)-78.78%
Max EPS beat(2)34.64%
EPS beat(4)2
Avg EPS beat(4)-12.3%
Min EPS beat(4)-157.35%
Max EPS beat(4)152.29%
EPS beat(8)5
Avg EPS beat(8)0.96%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.25%
Min Revenue beat(2)-20.18%
Max Revenue beat(2)-4.32%
Revenue beat(4)2
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-20.18%
Max Revenue beat(4)7.19%
Revenue beat(8)4
Avg Revenue beat(8)-1.09%
Revenue beat(12)4
Avg Revenue beat(12)-3.08%
Revenue beat(16)8
Avg Revenue beat(16)4.86%
PT rev (1m)0%
PT rev (3m)46.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-116.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB 3.79
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS2.6
BVpS1.81
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.97%
ROE -24.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.05%
FCFM N/A
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
F-Score3
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.92%
Cap/Sales 2.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z -8.98
F-Score3
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)30.78%
Cap/Depr(5y)28.81%
Cap/Sales(3y)1.85%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4900%
EPS 3Y-23.37%
EPS 5YN/A
EPS Q2Q%-105.88%
EPS Next Y-734.67%
EPS Next 2Y-45.37%
EPS Next 3Y66.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.64%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%-60.02%
Revenue Next Year-19.85%
Revenue Next 2Y21.58%
Revenue Next 3Y18.57%
Revenue Next 5YN/A
EBIT growth 1Y-231.15%
EBIT growth 3Y93.13%
EBIT growth 5YN/A
EBIT Next Year-130.54%
EBIT Next 3Y64.09%
EBIT Next 5YN/A
FCF growth 1Y-6.12%
FCF growth 3Y56.46%
FCF growth 5Y20.06%
OCF growth 1Y-6.81%
OCF growth 3Y52.8%
OCF growth 5Y17.54%

CINEVERSE CORP / CNVS Fundamental Analysis FAQ

What is the fundamental rating for CNVS stock?

ChartMill assigns a fundamental rating of 2 / 10 to CNVS.


What is the valuation status of CINEVERSE CORP (CNVS) stock?

ChartMill assigns a valuation rating of 1 / 10 to CINEVERSE CORP (CNVS). This can be considered as Overvalued.


How profitable is CINEVERSE CORP (CNVS) stock?

CINEVERSE CORP (CNVS) has a profitability rating of 2 / 10.


Can you provide the financial health for CNVS stock?

The financial health rating of CINEVERSE CORP (CNVS) is 2 / 10.


What is the earnings growth outlook for CINEVERSE CORP?

The Earnings per Share (EPS) of CINEVERSE CORP (CNVS) is expected to decline by -734.67% in the next year.